Enteral Feeding Devices Market Size and Share

Enteral Feeding Devices Market (2025 - 2030)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Enteral Feeding Devices Market Analysis by Mordor Intelligence

The enteral feeding devices market stands at USD 3.72 billion in 2025 and is on track to reach USD 4.94 billion by 2030, advancing at a 5.84% CAGR. The expansion reflects a steady switch from legacy feeding methods toward systems built around safety, digital connectivity, and ENFit-compliant fittings. Demographic pressures, especially longer lifespans and rising chronic illness prevalence, shore up baseline demand. Early compliance with ISO 80369-3 standards has become a clear competitive lever, rewarding manufacturers able to re-engineer product lines for the new connector format while accelerating consolidation among firms lacking the resources to adapt. Device makers that combine rigorous safety design with smart pumps, remote monitoring, and intuitive interfaces are now best placed to capture growth as care shifts into patient homes and outpatient centers.

Key Report Takeaways

  • By product type, feeding pumps led with a 39.67% revenue share in 2024, while feeding tubes are projected to register the fastest 6.87% CAGR to 2030.
  • By age group, the adult cohort held 72.45% of the enteral feeding devices market share in 2024; the pediatric & neonatal segment is forecast to expand at a 7.12% CAGR through 2030.
  • By distribution channel, offline routes dominated with 86.13% share in 2024, while online channels will post the strongest 7.23% CAGR. 
  • By application, oncology accounted for 30.28% of demand in 2024; critical care & trauma is set to rise at a 6.65% CAGR through 2030.
  • By end-user, hospitals contributed 53.90% in 2024, yet home care settings are growing at a 6.49% CAGR to 2030.
  • By geography, North America commanded 36.64% of 2024 revenue, whereas Asia Pacific is expected to grow the quickest at 6.68% CAGR to 2030.

Segment Analysis

By Product Type: Pumps Lead Despite Tube Innovation

In 2024, feeding pumps generated 39.67% of revenue, asserting dominance through dose accuracy and safety alarms. Volumetric units remain central to critical-care routines, but lightweight ambulatory models are rising fast as care decentralizes. The enteral feeding devices market size for tubes is climbing at a 6.87% CAGR, fueled by integrated cameras that guide bedside placement and cut X-ray exposure. Manufacturers bundle ENFit sets with both pumps and tubes, ensuring connector compliance[4]Janelle Harding, “ENFit Transition for Enteral Management in an Acute Care Setting,” Patient Safety Journal, patientsafetyj.com across the care pathway. A short-cycle replacement pattern for disposable giving sets further strengthens recurring revenues, drawing new capital into this portion of the enteral feeding devices market.

Regulatory scrutiny over syringes, categorized as Class II in the United States, has nudged vendors toward tamper-evident caps and color cues that prevent wrong-route errors. Bags and administration sets show slower but dependable uptake because every feed regimen needs consumables. Raw-material shortages in East Asia medical-grade plastics, however, expose the supply chain to volatility and may spur reshoring projects in North America and Europe.

Enteral Feeding Devices Market: Market Share by Product Type
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Age Group: Pediatric Segment Drives Innovation

Adults accounted for 72.45% of 2024 sales as chronic disorders and post-stroke care dominate procedure counts. Conversely, the pediatric & neonatal bracket is advancing at 7.12% CAGR on the back of expanding neonatal intensive-care capacity in emerging economies. Exclusive donor-milk protocols and AI-driven nutrient calculators shorten time to full feeds, reinforcing demand for calibrated syringes and low-volume pumps. 

The enteral feeding devices market share for neonatal-specific devices remains modest but premium, reflecting strict safety criteria and limited vendor competition. Supply gaps, notably syringe pump shortages that forced clinicians in some low-resource settings to adapt adult gear for infants, spotlight the need for resilient manufacturing footprints. Adult-focused design is now borrowing pediatric ergonomics to simplify use in the home, demonstrating cross-pollination benefits across the enteral feeding devices market.

By Distribution Channel: Online Growth Accelerates

Offline hospital procurement held 86.13% of orders in 2024 due to bundled service contracts and clinician training needs. Nonetheless, digital portals are on track for a 7.23% CAGR, the fastest among channels, as home users reorder feeding bags, syringes, and connectors directly through manufacturer storefronts. During the pandemic, health systems trialed click-and-collect models that now persist, opening incremental revenue streams in the enteral feeding devices market. 

Large suppliers partner with specialized medical-device e-commerce firms to navigate patchwork regulations. While pumps and placement kits still rely on distributor expertise, consumables shift online, especially in North America and parts of Europe where reimbursement codes support mail-order delivery. Smaller clinics in Southeast Asia are beginning to source basic tubes online to bypass local stockouts, underscoring the channel’s widening influence.

By Application: Oncology Leadership Faces Critical Care Challenge

Cancer therapies often impair swallowing, keeping oncology at the top with 30.28% of 2024 turnover. Outpatient infusion centers now incorporate portable pumps to sustain nutrition between chemotherapy cycles, fortifying sales momentum. Critical care & trauma procedures, however, are set to grow fastest at 6.65% CAGR as ICU expansions across India and China elevate baseline demand for early feed initiation protocols. 

Gastroenterology contributes steady volumes, with innovations like ultrasound-based intolerance scoring that tailor feeds and reduce complications. Smart sensors that pause pumps upon reflux aim to limit aspiration incidences, an acute issue for mechanically ventilated patients. Other uses—ranging from neurology to post-bariatric surgery—add niche opportunities that collectively lift the enteral feeding devices market size for diverse clinical departments.

Enteral Feeding Devices Market: Market Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By End-User: Home Care Transformation Accelerates

Hospitals still procure 53.90% of equipment, yet payer incentives for shorter stays power a 6.49% CAGR in home care settings. Wireless pumps capable of firmware updates and cloud dashboards give providers visibility into feed compliance, reducing readmissions. Training services bundled with initial device shipments differentiate sellers, especially where home health agencies struggle with staffing gaps. 

Ambulatory surgical centers embrace compact pumps for same-day procedures, further dispersing enteral nutrition beyond large hospitals. Long-term care facilities upgrade to ENFit tubing to align with national safety programs, steadily refreshing installed fleets. This realignment of care venues spreads the enteral feeding devices market across a broader purchaser base, smoothing revenue exposure to any single segment.

Geography Analysis

North America retained 36.64% of 2024 global spend, underpinned by wide reimbursement and early ENFit adoption. Growth, although slower at 5.14% CAGR, remains supported by home-based care models and federal incentives for telemonitoring devices. The FDA’s spotlight on pediatric device shortages has pushed suppliers to expand domestic molding and assembly, improving lead times and mitigating raw-material risks. 

Europe posts a 5.57% CAGR through 2030, aided by the Medical Device Regulation that standardizes approval requirements across member states. Harmonized rules lower administrative costs for multi-country launches and let manufacturers focus on differentiating features like app-enabled dose logging. Aging-in-place policies across Germany, France, and the Nordics encourage wider home feed adoption, especially via national nursing programs. Food for special medical purposes rules add complexity yet favor experienced firms that can document compliance. The enteral feeding devices market size tied to European home programs is set to climb steadily as municipalities integrate remote nutrition checks into routine elder care.

Asia Pacific marks the fastest regional pace at 6.68% CAGR owing to hospital building booms and expanding universal-health schemes in China and India. Yet access remains uneven; fewer than half of APAC nations reimburse home enteral formulas, so blenderized diets persist in lower-middle-income areas. Indian distributor Entero Healthcare registered 22% annual revenue growth in 2024, evidencing strong device appetite once funding barriers fall. To penetrate price-sensitive zones, global firms ally with local assemblers and offer tiered portfolios that pair low-cost tubes with optional smart features. These steps aim to convert nascent interest into durable gains for the enteral feeding devices market.

Enteral Feeding Devices Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Analysis on Important Geographic Markets
Download PDF

Competitive Landscape

The market skews toward a tight group of diversified healthcare companies that combine deep R&D, regulatory expertise, and broad service networks. Abbott clocked 13.7% Q4 2024 growth in its medical device unit, buoyed by connected enteral pump rollouts that integrate with its nutrition line. Fresenius Kabi secured a 2024 supply-chain excellence award, underlining operational resilience as a selling point amid resin shortages and freight volatility. 

Cardinal Health continues to extend its Kangaroo platform, layering wireless diagnostics and ENFit connectors across pump generations. Boston Scientific and Cook Medical focus on access devices and sensors that augment placement accuracy, a niche that shields margins from commoditized tubing. Meanwhile, ART Medical and other start-ups develop aspiration-prevention technologies, betting that hospitals will pay premiums for complication reduction. 

The ENFit switchover acts as a consolidation catalyst: tooling costs and validation cycles deter smaller rivals, leading to selective acquisitions and partnership deals to secure compliant product lines. Concurrently, vertical integration—such as in-house molding of connectors—strengthens supply surety. Firms that blend device hardware with cloud analytics and subscription consumables are poised to capture repeat revenue, a trend likely to shape strategic moves in the enteral feeding devices market through the decade.

Enteral Feeding Devices Industry Leaders

  1. Abbott Laboratories

  2. Becton, Dickinson and Company

  3. Cardinal Health Inc.

  4. Fresenius Kabi

  5. Medtronic plc

  6. *Disclaimer: Major Players sorted in no particular order
Enteral Feeding Devices Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • March 2025: Stanford Medicine reported an AI algorithm in Nature Medicine that optimizes intravenous nutrient blends for preterm infants, with potential crossover to enteral feeding protocols.
  • August 2024: Fresenius Kabi won the 2024 Premier Inc. Trailblazer Award for supply-chain innovation at its U.S. nutrition plant.
  • July 2024: The FDA cleared GT Metabolic Solutions’ MagDI System, expanding minimally invasive options that may alter post-procedure enteral strategies.
  • May 2024: Cook Medical partnered with EnteraSense to distribute the PillSense device in the United States, adding sensor-enabled monitoring to its enteral portfolio.

Table of Contents for Enteral Feeding Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Shift toward home & outpatient enteral nutrition
    • 4.2.2 Growing geriatric population & chronic disease burden
    • 4.2.3 Rapid adoption of ENFit-compliant connectors
    • 4.2.4 Rising premature births worldwide
    • 4.2.5 Growth of ambulatory cancer care requiring mobile pumps
    • 4.2.6 Value-based care incentives for early discharge with enteral kits
  • 4.3 Market Restraints
    • 4.3.1 Reimbursement gaps in low-income countries
    • 4.3.2 Regulatory uncertainty during ISO-80369-3 transition
    • 4.3.3 Tube-related complications & aspiration risks
    • 4.3.4 Medical-grade plastic supply chain constraints
  • 4.4 Supply Chain Analysis
  • 4.5 Porter's Five Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitutes
    • 4.5.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value)

  • 5.1 By Product Type
    • 5.1.1 Feeding Pumps
    • 5.1.1.1 Volumetric Pumps
    • 5.1.1.2 Ambulatory Pumps
    • 5.1.1.3 Syringe Pumps
    • 5.1.2 Feeding Tubes
    • 5.1.2.1 Nasogastric Tubes
    • 5.1.2.2 Gastrostomy Tubes
    • 5.1.2.3 Others
    • 5.1.3 Enteral Feeding Bags
    • 5.1.4 Administration Sets & Accessories
    • 5.1.5 Enteral Syringes
  • 5.2 By Age Group
    • 5.2.1 Adults
    • 5.2.2 Pediatric & Neonatal
  • 5.3 By Distribution Channel
    • 5.3.1 Offline
    • 5.3.2 Online
  • 5.4 By Application
    • 5.4.1 Oncology
    • 5.4.2 Gastroenterology
    • 5.4.3 Critical Care & Trauma
    • 5.4.4 Other Applications
  • 5.5 By End-User
    • 5.5.1 Hospitals
    • 5.5.2 Ambulatory Surgical Centers
    • 5.5.3 Home Care Settings
    • 5.5.4 Other End-Users
  • 5.6 By Geography
    • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
    • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 India
    • 5.6.3.3 Japan
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
    • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Competitive Benchmarking
  • 6.3 Market Share Analysis
  • 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.4.1 Abbott Laboratories
    • 6.4.2 ALCOR Scientific Inc.
    • 6.4.3 Amsino International Inc.
    • 6.4.4 Applied Medical Technology Inc.
    • 6.4.5 Avanos Medical Inc.
    • 6.4.6 B. Braun Melsungen AG
    • 6.4.7 Becton, Dickinson and Company
    • 6.4.8 Boston Scientific Corp.
    • 6.4.9 Cardinal Health Inc.
    • 6.4.10 ConMed Corporation
    • 6.4.11 Cook Medical Inc.
    • 6.4.12 Danone S.A.
    • 6.4.13 Fidmi Medical
    • 6.4.14 Fisher & Paykel Healthcare
    • 6.4.15 Fresenius Kabi
    • 6.4.16 Mead Johnson Nutrition
    • 6.4.17 Medtronic plc
    • 6.4.18 Micrel Medical Devices S.A.
    • 6.4.19 Moog Inc.
    • 6.4.20 Nestle S.A.
    • 6.4.21 Owens & Minor (Halyard Health)
    • 6.4.22 Vygon S.A.

7. Market Opportunities & Future Outlook

  • 7.1 White-Space & Unmet Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Research Methodology Framework and Report Scope

Market Definitions and Key Coverage

According to Mordor Intelligence, the enteral feeding devices market covers all pumps, tubes, administration sets, syringes, and related single-use accessories that deliver nutritionally complete formulas directly into the stomach or small intestine of patients with a functioning gastrointestinal tract. Value is recorded at manufacturer selling price before distributor rebates.

Scope exclusion: parenteral nutrition hardware, stand-alone enteral formulas, and general infusion pumps are not included.

Segmentation Overview

  • By Product Type
    • Feeding Pumps
      • Volumetric Pumps
      • Ambulatory Pumps
      • Syringe Pumps
    • Feeding Tubes
      • Nasogastric Tubes
      • Gastrostomy Tubes
      • Others
    • Enteral Feeding Bags
    • Administration Sets & Accessories
    • Enteral Syringes
  • By Age Group
    • Adults
    • Pediatric & Neonatal
  • By Distribution Channel
    • Offline
    • Online
  • By Application
    • Oncology
    • Gastroenterology
    • Critical Care & Trauma
    • Other Applications
  • By End-User
    • Hospitals
    • Ambulatory Surgical Centers
    • Home Care Settings
    • Other End-Users
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Detailed Research Methodology and Data Validation

Primary Research

Interviews with clinical dietitians, biomedical engineers, hospital supply managers, and home-care distributors across North America, Europe, and Asia helped validate average pump life, tube change frequency, and region-specific reimbursements. Responses also clarified the pace of ENFit retrofits and the typical price erosion faced by bulk purchasers.

Desk Research

We began with standard public datasets such as United Nations population projections, OECD hospitalization and procedure volumes, and WHO malnutrition prevalence. Trade groups like the Global Enteral Device Suppliers Association and clinical bodies publishing ENFit transition updates provided device replacement norms and connector adoption benchmarks. Company 10-Ks and FDA 510(k) listings clarified product pipelines, while cost trajectories were obtained from quarterly price indices released by the US Bureau of Labor Statistics. Proprietary pulls from D&B Hoovers and Dow Jones Factiva gave us historic revenue splits for key producers, anchoring channel mix assumptions. This list is illustrative; many additional open sources informed smaller data points.

Two further passes checked data coherence: our analysts compared customs import line items for feeding pumps in Asia Metal and cross-referenced shipment counts with voluntary recall notices, tightening baseline volumes.

Market-Sizing & Forecasting

We applied a top-down model that reconstructs global demand from inpatient tube placement and home-care prevalence data, which are then multiplied by verified replacement cycles. Supplier roll-ups of sampled ASP multiplied by volume gave a bottom-up sense-check before totals were finalized. Key drivers inside the model include oncology incidence, neonatal pre-term birth rates, elective surgery backlogs, ENFit compliance deadlines, average selling price trends, and shift toward portable pumps. Forecasts to 2030 rely on multivariate regression blended with scenario analysis so shocks in procedure volumes or pricing can be stress-tested.

Data Validation & Update Cycle

Outputs pass three layers of analyst review, variance checks against independent shipment statistics, and year-on-year growth sanity limits. Reports refresh annually, with interim updates triggered by major recalls, reimbursement shifts, or pandemic-level events, ensuring clients receive the latest view.

Why Mordor's Enteral Feeding Devices Baseline Commands Reliability

Published figures often diverge because firms vary device lists, bundle nutrition formulas, or freeze exchange rates at outdated levels. We disclose our scope, refresh every twelve months, and harmonize currencies at average annual rates, which keeps numbers comparable and current.

Benchmark comparison

Market Size Anonymized source Primary gap driver
USD 3.72 B (2025) Mordor Intelligence
USD 2.97 B (2025) Global Consultancy A excludes syringes and administration sets
USD 4.72 B (2025) Industry Association B merges devices with enteral formulas
USD 3.87 B (2024) Trade Journal C uses list prices before hospital discounts and older base year

The comparison shows how definition breadth, pricing basis, and refresh cadence explain most gaps. By selecting transparent variables and updating them regularly, Mordor Intelligence delivers a balanced, reproducible baseline that decision-makers can trust.

Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

Why are ENFit connectors considered a game-changer for enteral feeding device safety?

ENFit’s standardized geometry prevents misconnections with IV or respiratory lines, dramatically cutting wrong-route errors and making safety compliance a top purchasing criterion for hospitals and home-care agencies.

How is the shift to home enteral nutrition influencing device design?

Manufacturers now prioritize lightweight pumps with wireless monitoring, intuitive touch screens, and long-life batteries so caregivers can manage feeds confidently outside the hospital while clinicians track adherence remotely.

What innovation trends are emerging in neonatal enteral feeding?

Advances include AI-driven nutrient calculators for preterm infants and micro-volume pumps compatible with donor milk protocols, both aimed at accelerating time to full feeds and minimizing infection risk.

How are supply-chain pressures shaping competitive strategies in this market?

Firms are investing in in-house molding and regional manufacturing hubs to secure medical-grade plastics, ensuring steady component flow and creating a reliability advantage when tendering large health-system contracts

Why is aspiration risk management becoming a focal point for product differentiation?

Clinicians demand built-in sensors and auto-pause functions that detect reflux early, reducing pneumonia incidence and allowing providers to justify premium device pricing through improved patient safety outcomes.

How are digital platforms expanding revenue opportunities for device makers?

Cloud dashboards that track feeding parameters enable subscription models for analytics and consumables, transforming one-time equipment sales into recurring service relationships with hospitals and home-care teams.

Page last updated on: